Managers / Q4 2020 · view latest →
Lion Point Capital, LP
CIK 0001643354 · 375 PARK AVE, SUITE 2609, NEW YORK, NY, 10152 · 212-356-6200
Summary
Lion Point Capital, LP reported $519M in U.S.-listed holdings across 24 positions for Q4 2020.
Its largest position, TGTX, represents 13.3% of the portfolio.
Compared with Q3 2020, the fund opened 5 new positions and exited 5.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 85.3% · $443M
- Other · 8.8% · $46M
- ETP · 5.9% · $31M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| 0LSBURGERFI INTERNATIONAL INC | NEW | +2.75M | 2.75M | +$38M | $38M |
| INVESCO EXCH TRADED FD TR II | NEW | +300.0K | 300.0K | +$31M | $31M |
| 1T7TRICIDA INC | NEW | +1.83M | 1.83M | +$13M | $13M |
| BURGERFI INTERNATIONAL INC | NEW | +2.08M | 2.08M | +$5M | $5M |
| NXTCEURNEXTCURE INC | NEW | +300.0K | 300.0K | +$3M | $3M |
| AAALCOA CORP | SOLD OUT | −1.70M | 0 | −$20M | $0 |
| ISHARES TR | SOLD OUT | −93.0K | 0 | −$14M | $0 |
| LSCCLATTICE SEMICONDUCTOR CORP | SOLD OUT | −458.2K | 0 | −$13M | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2020
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $17M | 35 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $19M | 39 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $18M | 27 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $15M | 19 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $16M | 21 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $19M | 19 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $45M | 25 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $55M | 27 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $179M | 32 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $200M | 30 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $224M | 31 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $221M | 30 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $243M | 31 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $703M | 32 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $454M | 41 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $878M | 40 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $431M | 35 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $373M | 33 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $533M | 38 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $579M | 34 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $550M | 30 | May 19, 2021 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2020 | $519M | 24 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $456M | 24 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $412M | 24 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $379M | 25 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $1.1B | 26 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $897M | 26 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $1.0B | 24 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $1.1B | 24 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $636M | 35 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.